This is a OxyContin news story, published by Ars Technica, that relates primarily to Philip Colt Moss news.
For more OxyContin news, you can click here:
more OxyContin newsFor more Philip Colt Moss news, you can click here:
more Philip Colt Moss newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Ars Technica, you can click here:
more news from Ars TechnicaOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
lawyer Philip Colt Moss. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Philip Colt Moss news, felony drug charges news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
MossArs Technica
•
59% Informative
Philip Colt Moss was facing felony drug charges in 2017 after a raid on his home turned up marijuana , OxyContin , Klonopin , Xanax , Ambien , and Ritalin pills.
Moss' lawyer said his client was simply someone who "needs help" Moss now faces the possibility of years in federal prison.
VR Score
47
Informative language
37
Neutral language
54
Article tone
informal
Language
English
Language complexity
39
Offensive language
offensive
Hate speech
possibly hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
3
Affiliate links
no affiliate links